Illumina Inc. Announces 'Breakthrough Discovery' in Type-2 Diabetes Using Illumina's HumanHap300 and Human-1 Genotyping BeadChips.
Illumina Inc. announced that researchers using the Infinium??HumanHap300 and Human-1 BeadChips uncovered four important gene variations that increases the risk of developing type-2 diabetes, the most common form of the disease. These results were published in the journal,Nature, and are believed to explain up to 70% of the genetic background of type-2 diabetes.
